Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: An anti-androgen resistance-related gene signature acts as a prognostic marker and increases enzalutamide efficacy via PLK1 inhibition in prostate cancer

Fig. 2

Clustering of ARRDEGs revealed two PCa Subtypes with distinct baseline characteristics and survival outcomes. A–C Consensus matrix for k = 2, 3, and 4. D Heatmap illustrating the expression profiles of 941 DEGs between the two subtypes. E Volcano plot of the DEGs between the subtypes. F Recurrence-free survival of the two subtypes. G, H KEGG pathway and GO term enrichment analysis for DEGs between the two subtypes

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us